The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Patricia A. Russo, PhD, MSW, RN
Advertisement
Articles by Patricia A. Russo, PhD, MSW, RN
Advertisement
Latest Updated Articles
- Pharmacotherapy Timing in Heart Failure and Impact on Healthcare Costs
Published: November 16th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
3
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
4
When to Call, When to Counsel: Statin Drug Interactions
5
